LucyRx Acquires CerpassRx in First PBM Deal of 2025
According to a July 31 announcement, LucyRx has signed a definitive agreement to bring CerpassRx under its umbrella. The transaction is subject to regulatory approvals and customary closing conditions and is expected to close in Q3 2025. CerpassRx is a leading, full-service, pharmacy benefit manager (PBM) based in the Dallas-Fort Worth, Texas area. Its services include prescription optimization, flexible formulary designs, personalized member support and mail and specialty pharmacy programs. CerpassRx is a division of Nomi Health, a direct healthcare company. LucyRx is a PBM known for simplifying and improving access to prescription care. Partnering with more than 60,000 pharmacies, LucyRx... Read More »
Baptist Health EMS Engages in Strategic Merger with Rural Health Clinic in LevinPro Database
Baptist Health EMS has been linked to a significant merger or acquisition involving a rural health clinic, as reported in the LevinPro HC M&A deal database. This development connects Baptist Health EMS with Baptist Health Medical Group Inc, a distinguished not-for-profit rural health clinic headquartered at 705 Fairground Rd in Scottsburg, Indiana. This organization was formally incorporated on July 21, 2006. LevinPro HC, renowned for its comprehensive tracking of M&A activities across an extensive range of healthcare sectors—from hospitals and home health services to medical real estate and biopharma—has thoroughly profiled the transaction that involves Baptist Health Medical... Read More »
The IMA Group Acquires Medical Research Network in New York City
The IMA Group (IMA) announced on July 21 the acquisition of Medical Research Network for an undisclosed price. Medical Research Network is a U.S.-based clinical research site located in New York City, specializing in psychiatry and neurology trials focused on central nervous system (CNS) disorders. IMA provides government workers with medical, psychological and related evaluations, as well as ancillary services, assists payers with case management and occupational health management solutions and offers clinical research firms access to new advances in pharmacology and biotechnology for research subjects. Medical Research Network will continue operating under its current... Read More »
Evestia Clinical to Merge With Atlantic Research Group
Evestia Clinical announced on July 15 that it has merged with Charlottesville, Virginia-based Atlantic Research Group. Atlantic Research Group is a contract research organization (CRO) focused on oncology, immunology and neurology, The company provides comprehensive clinical program development services ranging from planning to commercialization, achieving more than 50 market authorizations to date. Evestia Clinical is a specialist full-service CRO specializing in clinical trials for oncology and rare diseases. It has office locations in the United States, the United Kingdom and Australia. The merger expands Evestia Clinical’s global footprint in the United States and broadens its... Read More »
Inside the 2025 ASC Market: Valuations, Hot Specialties & What’s Next
The ambulatory surgery center (ASC) market is facing a period of recalibration in 2025. A confluence of macroeconomic pressures, shifting specialty performance and evolving investment strategies has shaped the pace and structure of dealmaking across the sector. While demand for outpatient care remains strong, M&A activity has cooled, at least on the surface. To explore these trends, we interviewed Colin Park, Managing Director at VMG Health, a leading healthcare valuation and transaction advisory firm serving both buy-side and sell-side clients. Park’s insights reveal the forces currently shaping ASC M&A, the most resilient ASC specialties, how regulatory and cost pressures... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
